TY  - JOUR
AU  - Lagunes, L
AU  - Borgatta, B
AU  - Martín-Gomez, M T
AU  - Rey-Pérez, A
AU  - Antonelli, M
AU  - Righi, E
AU  - Merelli, M
AU  - Brugnaro, P
AU  - Dimopoulos, G
AU  - Garnacho-Montero, J
AU  - Colombo, A L
AU  - Luzzati, R
AU  - Menichetti, F
AU  - Muñoz, P
AU  - Nucci, M
AU  - Scotton, G
AU  - Viscoli, C
AU  - Tumbarello, M
AU  - Bassetti, M
AU  - Rello, J
AU  - IAC Study Investigators
PY  - 2016
DO  - 10.1016/j.cmi.2016.06.005
UR  - http://hdl.handle.net/10668/10284
T2  - Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
AB  - Intraabdominal candidiasis (IAC) is the second most frequent form of invasive candidiasis, and is associated with high mortality rates. This study aims to identify current practices in initial antifungal treatment (IAT) in a real-world scenario and to...
LA  - en
KW  - Adequate treatment
KW  - Antifungal therapy
KW  - Candida
KW  - Guidelines
KW  - Intraabdominal candidiasis
KW  - Invasive fungal disease
KW  - Septic shock
KW  - Aged
KW  - Antifungal Agents
KW  - Candidiasis, Invasive
KW  - Clinical Decision-Making
KW  - Consensus
KW  - Disease Management
KW  - Female
KW  - Humans
KW  - Intraabdominal Infections
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
TI  - Predictors of choice of initial antifungal treatment in intraabdominal candidiasis.
TY  - research article
VL  - 22
ER  -